These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15767037)

  • 61. Systemic reactions during skin tests with beta-lactams: a risk factor analysis.
    Co Minh HB; Bousquet PJ; Fontaine C; Kvedariene V; Demoly P
    J Allergy Clin Immunol; 2006 Feb; 117(2):466-8. PubMed ID: 16461151
    [No Abstract]   [Full Text] [Related]  

  • 62. Improving drug safety by locating genetic markers for hypersensitivity reactions.
    Ronaldson KJ; McNeil JJ
    Med J Aust; 2009 Jun; 190(11):641-3. PubMed ID: 19485844
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils.
    Kvedariene V; Kamey S; Ryckwaert Y; Rongier M; Bousquet J; Demoly P; Arnoux B
    Allergy; 2006 Mar; 61(3):311-5. PubMed ID: 16436139
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benzylpenicillin skin testing is still important in diagnosing immediate hypersensitivity reactions to penicillins.
    Romano A; Bousquet-Rouanet L; Viola M; Gaeta F; Demoly P; Bousquet PJ
    Allergy; 2009 Feb; 64(2):249-53. PubMed ID: 19133924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs.
    Naisbitt DJ; Nattrass RG; Ogese MO
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):691-705, x. PubMed ID: 25017686
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypersensitivity reactions to antineoplastic agents: an overview.
    Syrigou E; Makrilia N; Koti I; Saif MW; Syrigos KN
    Anticancer Drugs; 2009 Jan; 20(1):1-6. PubMed ID: 19342995
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quinolones-induced hypersensitivity reactions.
    Neuman MG; Cohen LB; Nanau RM
    Clin Biochem; 2015 Jul; 48(10-11):716-39. PubMed ID: 25895484
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity.
    Beeler A; Zaccaria L; Kawabata T; Gerber BO; Pichler WJ
    Allergy; 2008 Feb; 63(2):181-8. PubMed ID: 18005225
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Cutaneous drug reactions].
    Lützow-Holm C; Rønnevig JR
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2483-7. PubMed ID: 16186866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Recommendations of antimicrobial treatment in patients allergic to beta-lactam antibiotics].
    Barberán J; Mensa J; Fariñas C; Llinares P; Olaechea P; Palomar M; Torres M; Moreno E; Serrano R; García J
    Rev Esp Quimioter; 2008 Mar; 21(1):60-82. PubMed ID: 18443934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical symptoms and mechanisms of drug-induced allergic reactions].
    Patkowski J; Małolepszy J; Ciepichał J
    Postepy Hig Med Dosw; 1986; 40(6):635-56. PubMed ID: 3299339
    [No Abstract]   [Full Text] [Related]  

  • 72. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.
    Nizankowska-Mogilnicka E; Bochenek G; Mastalerz L; Swierczyńska M; Picado C; Scadding G; Kowalski ML; Setkowicz M; Ring J; Brockow K; Bachert C; Wöhrl S; Dahlén B; Szczeklik A
    Allergy; 2007 Oct; 62(10):1111-8. PubMed ID: 17521312
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan.
    Goomer RS; Leslie K; Maris T; Amiel D
    Clin Orthop Relat Res; 2005 May; (434):239-45. PubMed ID: 15864059
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The contribution of major and minor determinants from benzylpenicillin to the diagnosis of immediate allergy to beta-lactams.
    Torres MJ; Blanca M
    J Allergy Clin Immunol; 2006 Jan; 117(1):220-1; author reply 221. PubMed ID: 16387613
    [No Abstract]   [Full Text] [Related]  

  • 76. Diagnostic testing in suspected fluoroquinolone hypersensitivity.
    Seitz CS; Bröcker EB; Trautmann A
    Clin Exp Allergy; 2009 Nov; 39(11):1738-45. PubMed ID: 19735271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Life-threatening dermatoses in travelers.
    Millikan LE
    Clin Dermatol; 2005; 23(3):249-53. PubMed ID: 15896539
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective immediate hypersensitivity to cefodizime.
    Romano A; Viola M; Guéant-Rodriguez RM; Valluzzi RL; Guéant JL
    Allergy; 2005 Dec; 60(12):1545-6. PubMed ID: 16266391
    [No Abstract]   [Full Text] [Related]  

  • 79. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.
    Todd G
    Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immediate hypersensitivity to penicillins with negative skin tests--the value of specific IgE.
    Silva R; Cruz L; Botelho C; Castro E; Cadinha S; Castel-Branco MG; Rodrigues J
    Eur Ann Allergy Clin Immunol; 2009 Aug; 41(4):117-9. PubMed ID: 19877564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.